-
Capecitabine, sold
under the
brand name
Xeloda among others, is a
anticancer medication used to
treat breast cancer,
gastric cancer and
colorectal cancer...
- is a
kinase inhibitor indicated in
combination with
trastuzumab and
capecitabine for the
treatment of
adults with
advanced unresectable or metastatic...
-
months vs. 25.1 months)
compared to the
combination of
lapatinib and
capecitabine.
Based on that trial, the U.S. Food and Drug
Administration (FDA) approved...
-
CAPOX (also
called XELOX) is a
chemotherapy regimen consisting of
capecitabine (trade name Xeloda)
combined with oxaliplatin.
Xelox regime operates in...
-
lapatinib in
combination therapy for
breast cancer patients already using capecitabine (Xeloda). In
January 2010,
Tykerb received accelerated approval for the...
- cabozantinib, cytarabine, doxorubicin, and
fluorouracil and its
prodrug capecitabine.
Targeted cancer therapies,
especially the
tyrosine kinase inhibitors...
-
Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine Cytarabine Doxifluridine Fluorouracil Gemcitabine Hydroxyurea Mercaptopurine...
-
following an
overdose of
chemotherapy drugs 5-fluorouracil (5-FU) or
capecitabine regardless of the
presence of symptoms, or who
exhibit early-onset, severe...
- com. Walsh, Sandy. "Press
Announcements - FDA
approves first generic capecitabine to
treat colorectal and
breast cancers". www.fda.gov.
United States Food...
- 5-fluorouracil, leucovorin, and irinotecan. The
regimen XELIRI consists of
capecitabine and irinotecan. It may also be used
together with
fluorouracil and folinic...
